Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BAROSTIM NEO Hypertension Pivotal Trial

NCT: NCT01679132 · COMPLETED

NCT IDNCT01679132
StatusCOMPLETED
Start Date2013-04-12
Completion2025-07-23
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the BAROSTIM Hypertension Pivotal Trial (G120137).

Frequently Asked Questions

What is BAROSTIM NEO Hypertension Pivotal Trial?

BAROSTIM NEO Hypertension Pivotal Trial is a clinical trial registered under NCT01679132. Current status: COMPLETED.

What is the status of NCT01679132?

The current status of NCT01679132 (BAROSTIM NEO Hypertension Pivotal Trial) is: COMPLETED.

When did BAROSTIM NEO Hypertension Pivotal Trial start?

BAROSTIM NEO Hypertension Pivotal Trial started on 2013-04-12.

Related Devices

PMA P180050Stimulator, carotid sinus nerveCvrx, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑